This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Favorite Picks from 'The Forever Portfolio'

Clean Water: Half of the hospital beds in the world are filled right this second by people suffering from diseases related to unclean water. While the world's population has doubled since 1950, our use of water has tripled. And how much more water is there to drink? Zero change. Consequently, ever-larger portions of the planet are using water that is deemed unsafe by current U.S. standards. Stock Pick No. 6: Idexx Laboratories (IDXX - Get Report) has a growing division that detects biological contaminants in water. This is not only a clean-water play but also a terrorism play. Additionally, the company has products that help diagnose illness in animals. So they are good to cats.

Auto Safety: The last time I drove, many, many people suffered. I'm sorry. Last year there were more than 1 million auto-related deaths. That number is only increasing as people all over the world participate in the rural-to-urban move taking place in all emerging economies. Stock Pick No. 7: Autoliv (ALV - Get Report) has with a 7% dividend and is the leader in auto safety. It holds the patents on airbags, seatbelts, etc. The U.S. mandates that all of these products be put in cars, and other countries are only beginning to follow suit. When they do, they go to Autoliv.

Consolation prizes:

  • Chocolate: Stock Pick No. 8: Hershey (HSY - Get Report)
  • See better: Stock Pick No. 9: Luxottica (LUX - Get Report)
  • Avoid a pandemic: Stock Pick No. 10: Genzyme (GENZ)

I really don't like to worry. In markets like this that go up or down 5% a day, it's too stressful to be starting at a quote screen. But if you know that you are in investments with solid balance sheets that are helping solve the world's ills -- particularly as those ills get ever greater due to demographics -- then you can rest easy at night.

Sweet dreams.


Please note that due to factors including low market capitalization and/or insufficient public float, we consider Cynosure, Cutera and Intersections to be small-cap stocks. You should be aware that such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information, and that postings such as this one can have an effect on their stock prices.

At the time of publication, Altucher and/or his fund was long Goldman Sachs and Autoliv, although positions may change at any time.

James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the Financial Times and the author of Trade Like a Hedge Fund, Trade Like Warren Buffett and SuperCa$h. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

4 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ALV $130.41 0.00%
CUTR $14.36 0.00%
CYNO $36.00 0.00%
GS $207.80 0.00%
IDXX $138.72 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs